Reactive oxygen species and cellular oxygen sensing

TP Cash, Y Pan, MC Simon - Free Radical Biology and Medicine, 2007 - Elsevier
TP Cash, Y Pan, MC Simon
Free Radical Biology and Medicine, 2007Elsevier
Many organisms activate adaptive transcriptional programs to help them cope with
decreased oxygen (O2) levels, or hypoxia, in their environment. These responses are
triggered by various O2 sensing systems in bacteria, yeast and metazoans. In metazoans,
the hypoxia inducible factors (HIFs) mediate the adaptive transcriptional response to
hypoxia by upregulating genes involved in maintaining bioenergetic homeostasis. The HIFs
in turn are regulated by HIF-specific prolyl hydroxlase activity, which is sensitive to cellular …
Many organisms activate adaptive transcriptional programs to help them cope with decreased oxygen (O2) levels, or hypoxia, in their environment. These responses are triggered by various O2 sensing systems in bacteria, yeast and metazoans. In metazoans, the hypoxia inducible factors (HIFs) mediate the adaptive transcriptional response to hypoxia by upregulating genes involved in maintaining bioenergetic homeostasis. The HIFs in turn are regulated by HIF-specific prolyl hydroxlase activity, which is sensitive to cellular O2 levels and other factors such as tricarboxylic acid cycle metabolites and reactive oxygen species (ROS). Establishing a role for ROS in cellular oxygen sensing has been challenging since ROS are intrinsically unstable and difficult to measure. However, recent advances in fluorescence energy transfer resonance (FRET)-based methods for measuring ROS are alleviating some of the previous difficulties associated with dyes and luminescent chemicals. In addition, new genetic models have demonstrated that functional mitochondrial electron transport and associated ROS production during hypoxia are required for HIF stabilization in mammalian cells. Current efforts are directed at determining how ROS mediate prolyl hydroxylase activity and hypoxic HIF stabilization. Progress in understanding this process has been enhanced by the development of the FRET-based ROS probe, an vivo prolyl hydroxylase reporter and various genetic models harboring mutations in components of the mitochondrial electron transport chain.
Elsevier